Company Overview
| Stock Name | Ritamix |
|---|---|
| Stock Code | 01936 |
| Company Full Name | To be extracted |
| Industry | 飼料添加劑 |
| Principal Activities | 我們為一間扎根於馬來西亞的公司,主要從事 (i) 分銷動物飼料添加劑及較少的人類食品配料;及 (ii) 生產動物飼料添加劑預混料。 |
| Listing Date | 2020-05-13 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港灣仔譚臣道98號運盛大廈13樓B室 |
| Business Address (Hong Kong) | 香港北角電氣道148號31樓 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | ritamix-global.com |
| Share Registrar | 宝德隆 |
| Registrar Contact | (852)2153 1688 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 1.00 / shares |
| Offer Price Range | Final offer price only, no range |
| Lot Size | 2,000 shares |
| Entry Threshold | HK$ 2,000 |
| Par Value | RMB 0.01 / shares |
| Offer Period | 2020-05-04 to 2020-05-04 |
| Global Offering Shares | 125,000,000 shares |
| HK Public Offer Shares (Initial) | 12,500,000 shares (10.0%) |
| Public Offer Lots (Initial) | 6,250lots (Pool A3,125lots,Pool B3,125lots) |
| International Placing Shares (Initial) | 112,500,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 500,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 28.8% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 125,000,000 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 2,000 | HK$ 2,000 |
| 2 lots | 4,000 | HK$ 4,000 |
| 3 lots | 6,000 | HK$ 6,000 |
| 4 lots | 8,000 | HK$ 8,000 |
| 5 lots | 10,000 | HK$ 10,000 |
| 6 lots | 12,000 | HK$ 12,000 |
| 7 lots | 14,000 | HK$ 14,000 |
| 8 lots | 16,000 | HK$ 16,000 |
| 9 lots | 18,000 | HK$ 18,000 |
| 10 lots | 20,000 | HK$ 20,000 |
| 15 lots | 30,000 | HK$ 30,000 |
| 20 lots | 40,000 | HK$ 40,000 |
| 25 lots | 50,000 | HK$ 50,000 |
| 30 lots | 60,000 | HK$ 60,000 |
| 40 lots | 80,000 | HK$ 80,000 |
| 50 lots | 100,000 | HK$ 100,000 |
| 75 lots | 150,000 | HK$ 150,000 |
| 100 lots | 200,000 | HK$ 200,000 |
| 150 lots | 300,000 | HK$ 300,000 |
| 200 lots | 400,000 | HK$ 400,000 |
| 250 lots | 500,000 | HK$ 500,000 |
| 300 lots | 600,000 | HK$ 600,000 |
| 400 lots | 800,000 | HK$ 800,000 |
| 2,250 lots | 4,500,000 | HK$ 4,500,000 |
| 2,500 lots | 5,000,000 | HK$ 5,000,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| HK Market Cap | HK$ 1B |
| Est. Threshold | HK$ 9.39B |
| Analysis Result | HK market cap below threshold, need +839% |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 500,000,000 |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約13.7百萬令吉 |
| Period-End Cash Balance | 令吉6.5百萬元 |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2017 | 2018 | 2019 |
|---|---|---|---|
| Revenue | 108,062 | 128,600 | 126,053 |
| Cost of sales | -85,494 | -92,174 | -96,791 |
| Gross profit | 22,568 | 36,426 | 29,262 |
| Other income and gains, net | 1,714 | 1,575 | 1,542 |
| Selling and distribution expenses | -1,961 | -2,257 | -2,125 |
| Administrative expenses | -7,299 | -8,146 | -7,433 |
| Operating profit | 14,558 | 22,180 | 19,031 |
| Net finance costs | 0 | -15 | -146 |
| Profit before tax | 14,558 | 22,165 | 18,885 |
| Income tax expense | -3,702 | -6,259 | -5,167 |
| Profit for the year | 10,856 | 15,906 | 13,718 |
Balance Sheet
| Item | 2017 | 2018 | 2019 |
|---|---|---|---|
| Cash and cash equivalents | 3,896 | 6,222 | 6,482 |
| Trade and bills receivables | 29,576 | 28,969 | 38,528 |
| Inventories | 31,666 | 27,989 | 31,611 |
| Total current assets | 72,831 | 73,263 | 81,616 |
| Total assets | 87,564 | 87,583 | 95,784 |
| Total current liabilities | 17,403 | 16,504 | 10,909 |
| Total liabilities | 17,953 | 17,066 | 11,549 |
| Total equity | 69,611 | 70,517 | 84,235 |
| Equity attributable to owners | 69,611 | 70,517 | 84,235 |
| Interest-bearing borrowings | 0 | 2,172 | 1,509 |
Cash Flow Statement
| Item | 2017 | 2018 | 2019 |
|---|---|---|---|
| Net cash from operating activities | 1,180 | 23,555 | -3,239 |
| Net cash from investing activities | -2,153 | -2,386 | 4,866 |
| Net cash from financing activities | -4,200 | -18,843 | -1,367 |
| Net increase in cash | -5,173 | 2,326 | 260 |
| Depreciation of PP&E | 973 | 985 | 1,431 |
| Purchase of PP&E | -556 | -572 | -690 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 2.76 |
|---|---|
| First Day Open | HK$ 2.01 |
| First Day Change | 176.00% |
| First Day Volume | 52224000.0 |
| First Day Turnover | 107739000.0 |
| Use of Proceeds | 1、約42.1百萬港元(約58.1%)將用作建造新生產工廠的部分資金,以提高產能;
2、約13.4百萬港元(約18.5%)將用作潛在收購及/或與馬來西亞公司進行商業合作的資金,可與現有產品組合相輔相成;
3、約3.5百萬港元(約4.9%)將用于建立新測試實驗室,對客戶的飼料進行細菌毒素及霉菌毒素檢測分析,為客戶提供補充服務;
4、約3.7百萬港元(約5.1%)將用于設立涵蓋各類功能的集中ERP系統,包括銷售、購買、生產、倉儲及會計;
5、約1.7百萬港元(約2.4%)將用于進一步打入動物飼料添加劑及人類食品配料市場,主要方式為進行銷售及營銷活動;
6、約3.0百萬港元(約4.1%)將用于招聘(i)新生產工廠的12名操作人員;(ii)新測試實驗室的三名實驗室助理;(iii)三名獸醫╱營養師,加強我們的銷售及技術團隊;及(iv)財務行政部及倉儲部的七名后勤人員;
7、約1.4百萬港元(約2.0%)將用于購買采購及銷售物流的三輛卡車及銷售人員的九輛汽車;
8、約3.6百萬港元(約4.9%)將用作本集團一般營運資金用途。 |
Underwriting Syndicate
Sole Sponsor (1)
Messis Capital Limited CE AHH635
Joint Bookrunners (1)
Astrum Capital Management Limited (HK) CE ALY555
Joint Lead Managers (3)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | China Peace Limited | 24,000,000 HKD | — | 19.20% | — | 6 months | 2020-11-13 |
| 2 | 黄翔弘 | 12,000,000 HKD | — | 9.60% | — | 6 months | 2020-11-13 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | Lee Haw Yih | — |
| Company Secretary | 郭兆文黎剎騎士 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Garry-Worth持股67.5%;拿督斯里Howard Lee、HH Lee先生、HS Lee先生及拿汀斯里Emerlyn Yaw作為一致行動人士合共控制67.5%股權;首次公開發售前投資者持股7.5% |
|---|




